Winton Group’s Calithera Biosciences, Inc CALA Stock Holding History

Winton Group’s Portfolio CALA Stock Details CALA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-4,102	Closed	-$468K	–	1591
2019 Q4	$468K	Buy	+4,102	New	+$309K	0.01%	1261

Other funds holding CALA

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

Winton Group's CALA Position: Q1 2020 in Review

Winton Group sold out of Calithera Biosciences, Inc (CALA) in Q1 2020, closing a stake of 4,102 shares — an estimated $468K sold.

Winton Group first reported a position in CALA in Q4 2019 and held it in 1 quarter. The position peaked at $468K in Q4 2019. 80 funds tracked by Wall St. Rank hold CALA as of Q1 2020.

Winton Group reported no remaining Calithera Biosciences, Inc position as of Q1 2020 after selling out during the quarter.
Winton Group sold 4,102 Calithera Biosciences, Inc shares in Q1 2020, an estimated $468K.
Winton Group first reported a position in Calithera Biosciences, Inc in Q4 2019 and held it in 1 quarter.
Winton Group's Calithera Biosciences, Inc position peaked at $468K in Q4 2019.
80 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q1 2020.

Based on Winton Group's 13F filing for Q1 2020, filed 11 May 2020.